GB0030700D0 - Membrane signalling networks - Google Patents
Membrane signalling networksInfo
- Publication number
- GB0030700D0 GB0030700D0 GBGB0030700.9A GB0030700A GB0030700D0 GB 0030700 D0 GB0030700 D0 GB 0030700D0 GB 0030700 A GB0030700 A GB 0030700A GB 0030700 D0 GB0030700 D0 GB 0030700D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- signalling networks
- membrane signalling
- membrane
- networks
- signalling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/5055—Cells of the immune system involving macrophages
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0030700.9A GB0030700D0 (en) | 2000-12-15 | 2000-12-15 | Membrane signalling networks |
PCT/GB2001/005591 WO2002048709A1 (en) | 2000-12-15 | 2001-12-17 | Membrane signalling networks |
AU2002222250A AU2002222250A1 (en) | 2000-12-15 | 2001-12-17 | Membrane signalling networks |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0030700.9A GB0030700D0 (en) | 2000-12-15 | 2000-12-15 | Membrane signalling networks |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0030700D0 true GB0030700D0 (en) | 2001-01-31 |
Family
ID=9905214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0030700.9A Ceased GB0030700D0 (en) | 2000-12-15 | 2000-12-15 | Membrane signalling networks |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002222250A1 (en) |
GB (1) | GB0030700D0 (en) |
WO (1) | WO2002048709A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20010688A1 (en) | 2001-11-21 | 2003-05-21 | Univ Roma | IMMUNOREGULATORY COMPOUNDS. |
GB0513431D0 (en) | 2005-06-30 | 2005-08-10 | Kherion Technology Ltd | Prophylactic compositions and uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643599A (en) * | 1995-06-07 | 1997-07-01 | President And Fellows Of Harvard College | Intracellular delivery of macromolecules |
US6054133A (en) * | 1997-07-10 | 2000-04-25 | The Regents Of The University Of California | Anti-microbial targeting for intracellular pathogens |
-
2000
- 2000-12-15 GB GBGB0030700.9A patent/GB0030700D0/en not_active Ceased
-
2001
- 2001-12-17 AU AU2002222250A patent/AU2002222250A1/en not_active Abandoned
- 2001-12-17 WO PCT/GB2001/005591 patent/WO2002048709A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002222250A1 (en) | 2002-06-24 |
WO2002048709A1 (en) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2361389B (en) | Telecommunications system | |
GB2371442B (en) | Monitoring communications networks | |
AU9495501A (en) | Communication system | |
AU2001249070A1 (en) | International signaling gateway | |
EP1199736A4 (en) | Membrane switch | |
EP1358255A4 (en) | Porous polymers | |
GB0130431D0 (en) | Permeable membrane | |
AU2001254959A1 (en) | Test signalling | |
AU2002212445A1 (en) | Signalling means | |
GB0130318D0 (en) | Membrane | |
AU2002211150A1 (en) | Traffic signalling | |
FI20000362A0 (en) | The packet network telephone system | |
GB0030700D0 (en) | Membrane signalling networks | |
GB0008084D0 (en) | Telecommunications system | |
GB0016368D0 (en) | Membrane systems | |
GB0020802D0 (en) | Signalling gateway redundancy | |
GB0021798D0 (en) | Telephony system | |
GB0021510D0 (en) | Telecommunication systems | |
DE50015715D1 (en) | Optischer crossconnect | |
GB0130197D0 (en) | Membrane | |
GB0010182D0 (en) | Communication system | |
GB0009466D0 (en) | Communication system | |
GB2368239B (en) | Telecommunications system | |
GB0106915D0 (en) | Improved communication system | |
GB0013130D0 (en) | Microporous membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |